Aldeyra Therapeutics Inc
Aldeyra Therapeutics Inc
ALDX

Aldeyra Therapeutics Inc (ALDX)

$3.991.53%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$3.81
Day's Range
$4.04
$2.36
52-Week Range
$11.45
1 month return27.18%
3 month return16.56%
1 year return63.51%
5 year return20.61%

Company Information

Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company's lead investigational compounds, reproxalap and ADX-629, target RASP (reactive aldehyde species), which are elevated in ocular and systemic inflammatory disease and result in cytokine release via activation of a broad array of inflammatory factors, including NF-κB, inflammasomes, and Scavenger Receptor A. Reproxalap is being evaluated in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. The company's clinical pipeline also includes ADX-2191, a dihydrofolate reductase inhibitor in Phase 3 testing for proliferative vitreoretinopathy, and ADX-1612, a chaperome inhibitor in development for COVID-19 and ovarian cancer.
OrganizationAldeyra Therapeutics Inc
Employees11
CEO
IndustryHealth Technology

Analyst Recommendation

based on 16 analysts ratings

Buy
93%
Buy
6%
Hold
0%
Sell

Based on 16 Wall street analysts offering stock ratings for Aldeyra Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 356.14%

Current

$3.99

Target

$18.2

Recommendation Trend

Based on 16 analyst

Current1M Ago3M Ago
Buy
15
15
16
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
195.8M
Book Value
3.54
Dividend Share
0.0
Dividend Yield
0.0
Earnings Share
-1.07
PEG Ratio
0.0
Wall Street Target Price
20.2

Valuation

Trailing PE0.0
Forward PE0.0
Price/Sales (ttm)
0.0
Price/Book (mrq)
0.96
Enterprise Value
-19788482
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.35

Technicals

Beta
1.51
50 Day MA
4.25
200 Day MA
6.57

Institutional Holdings

Perceptive Advisors LLC

16.99%

BlackRock Inc

5.54%

Vanguard Group Inc

5.08%

Verition Fund Managegment, LLC

3.61%

Eagle Asset Management, Inc.

2.53%

Tri Locum Partners LP

2.48%

Discover more

Frequently Asked Questions

What is Aldeyra Therapeutics Inc share price today?

Can Indians buy Aldeyra Therapeutics Inc shares?

How can I buy Aldeyra Therapeutics Inc shares from India?

Can Fractional shares of Aldeyra Therapeutics Inc be purchased?

What are the documents required to start investing in Aldeyra Therapeutics Inc stocks?

What are today’s High and Low prices of Aldeyra Therapeutics Inc?

What are today’s traded volumes of Aldeyra Therapeutics Inc?

What is today’s market capitalisation of Aldeyra Therapeutics Inc?

What is the 52 Week High and Low Range of Aldeyra Therapeutics Inc?

How much percentage Aldeyra Therapeutics Inc is down from its 52 Week High?

How much percentage Aldeyra Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Aldeyra Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Aldeyra Therapeutics Inc?